IL3 and acute lymphoblastic leukemia: According to the fifth edition of the World Health Organization Classification of Hematolymphoid Tumors, the IGH::IL3 fusion defines a distinct molecular subtype of B‐cell precursor acute lymphoblastic leukemia (BCP‐ALL) [1].